1. Effects of Glycyrrhizic Acid on the Pharmacokinetics of Pristimerin in Rats and its Potential Mechanism
    Xiufen Zhao et al, 2017, Eur J Drug Metab Pharmacokinet CrossRef
  2. Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin
    YONG BO LIU et al, 2014 CrossRef
  3. Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells
    DORRAH DEEB et al, 2015 CrossRef
  4. Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins
    BASHIR A. YOUSEF et al, 2016 CrossRef
  5. Induction of cell cycle arrest and apoptosis by betulinic acid-rich fraction from Dillenia suffruticosa root in MCF-7 cells involved p53/p21 and mitochondrial signalling pathway.
    Jhi Biau Foo et al, 2015, J Ethnopharmacol CrossRef
  6. MG132 enhances the radiosensitivity of lung cancer cells in vitro and in vivo.
    Wei Zhu et al, 2015, Oncol Rep CrossRef
  7. Inhibition of hTERT in pancreatic cancer cells by pristimerin involves suppression of epigenetic regulators of gene transcription
    Dorrah Deeb et al, 2017 CrossRef
  8. Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling
    GUI'E XIE et al, 2016 CrossRef
  9. Decreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC
    Yinzhou Xiang et al, 2017 CrossRef
  10. Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-кB signaling pathway in colorectal cancer cells
    Bashir A. Yousef et al, 2018, Phytomedicine CrossRef
  11. Pristimerin, a naturally occurring triterpenoid, attenuates tumorigenesis in experimental colitis-associated colon cancer
    Ju-Hyung Park et al, 2018, Phytomedicine CrossRef
  12. null
    Nagendra Sastry Yarla et al, 2017 CrossRef
  13. Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
    Dina S. El-Agamy et al, 2018, Front. Pharmacol. CrossRef
  14. In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes
    Xiaoyi Hao et al, 2018, Xenobiotica CrossRef
  15. Pristimerin, a Naturally Occurring Triterpenoid, Exerts Potent Anticancer Effect in Colon Cancer Cells
    Hee Won Seo et al, 2018, BSL CrossRef
  16. null
    Alírica Isabel Suárez et al, 2018 CrossRef
  17. A pentacyclic triterpene derivative possessing polyhydroxyl ring A suppresses growth of HeLa cells by reactive oxygen species-dependent NF-κB pathway
    Ri-Zhen Huang et al, 2018, European Journal of Pharmacology CrossRef
  18. Induction of cell-cycle arrest and apoptosis in human cholangiocarcinoma cells by pristimerin
    Jian-min Sun et al, 2019, J Cell Biochem CrossRef
  19. Development and Validation of an HPLC-PDA Method for Biologically Active Quinonemethide Triterpenoids Isolated from Maytenus chiapensis
    Vito Taddeo et al, 2019, Medicines CrossRef
  20. Mevalonate-derived quinonemethide triterpenoid from in vitro roots of Peritassa laevigata and their localization in root tissue by MALDI imaging
    Edieidia S. Pina et al, 2016, Sci Rep CrossRef
  21. A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells.
    Peng Huang et al, 2019, Anal Cell Pathol (Amst) CrossRef
  22. Pristimerin Inhibits Inducible Nitric Oxide Synthase Expression Induced by TLR Agonists
    Su-Yeon Kim et al, 2019, BSL CrossRef
  23. Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
    Jia-jun Li et al, 2019, Front. Pharmacol. CrossRef
  24. Pristimerin, a natural anti-tumor triterpenoid, inhibits LPS-induced TNF-α and IL-8 production through down-regulation of ROS-related classical NF-κB pathway in THP-1 cells
    Bin Hui et al, 2014, International Immunopharmacology CrossRef
  25. Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors
    Riccardo Zanni et al, 2015, PLoS ONE CrossRef
  26. M2 Macrophages Enhance the Cementoblastic Differentiation of Periodontal Ligament Stem Cells via the Akt and JNK Pathways
    Xuan Li et al, 2019, Stem Cells CrossRef
  27. Absorption and metabolism characteristics of pristimerin as determined by a sensitive and reliable LC–MS/MS method
    Chuanhai Dong et al, 2015, Fitoterapia CrossRef
  28. Influence of verapamil on pharmacokinetics of pristimerin in rats
    Xiaodong Gao et al, 2016, Biomed. Chromatogr. CrossRef
  29. Ultrasound-Assisted Extraction of Pristimerin from Celastrus orbiculatus Using Response Surface Methodology
    Gong Fang et al, 2016, Biological & Pharmaceutical Bulletin CrossRef
  30. Pristimerin attenuates ovalbumin-induced allergic airway inflammation in mice
    Yingli Jin et al, 2016, Immunopharmacology and Immunotoxicology CrossRef
  31. Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin‐like growth factor‐1 receptor and its downstream pathways
    Xinshu Xie et al, 2019, J Cell Mol Med CrossRef
  32. Improved production of quinone-methide triterpenoids by Cheiloclinium cognatum root cultures: possibilities for a non-destructive biotechnological process
    Edieidia S. Pina et al, 2017, Plant Cell Tiss Organ Cult CrossRef
  33. Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
    Elaine C. D. Gonçalves et al, 2020, Molecules CrossRef
  34. Pristimerin‐induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway
    Fengxia Yan et al, 2020, J Cell Mol Med CrossRef
  35. Pristimerin Exacerbates Cellular Injury in Conditionally Reprogrammed Patient-Derived Lung Adenocarcinoma Cells by Aggravating Mitochondrial Impairment and Endoplasmic Reticulum Stress through EphB4/CDC42/N-WASP Signaling
    Yubo Tang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  36. Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells
    Yingbing Zhang et al, 2019, Int J Mol Med CrossRef
  37. Pristimerin induces apoptosis of oral squamous cell carcinoma cells via G1 phase arrest and MAPK/Erk1/2 and Akt signaling inhibition.
    Haiyan Wu et al, 2019, Oncol Lett CrossRef
  38. 22β-hydroxytingenone induces apoptosis and suppresses invasiveness of melanoma cells by inhibiting MMP-9 activity and MAPK signaling
    Elenn Suzany Pereira Aranha et al, 2020, Journal of Ethnopharmacology CrossRef
  39. Synergistic anti-cancer effect of pristimerin and docetaxel on human colorectal HCT-116 cells
    Bashir A. Yousef et al, 2020, Synergy CrossRef
  40. Pristimerin synergizes with gemcitabine through abrogating Chk1/53BP1-mediated DNA repair in pancreatic cancer cells
    Zhuangzhuang Jiang et al, 2020, Food and Chemical Toxicology CrossRef
  41. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells
    Selvi Kunnimalaiyaan et al, 2015, Mol Cancer Ther CrossRef
  42. Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells
    Xue-Tao Xu et al, 2020, European Journal of Pharmacology CrossRef
  43. Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
    Dahu Qi et al, 2021, Front. Pharmacol. CrossRef
  44. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway
    Yubo Tang et al, 2021, Phytomedicine CrossRef
  45. Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
    Run-Ze Chen et al, 2021, Front. Oncol. CrossRef
  46. Targeting Bcl-2 for cancer therapy
    Linlin Zhang et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  47. In Vitro Production and Exudation of 20-Hydroxymaytenin from Gymnosporia heterophylla (Eckl. and Zeyh.) Loes. Cell Culture
    Thanet Pitakbut et al, 2021, Plants CrossRef
  48. Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway
    Qun Zhao et al, 2021, Phytomedicine CrossRef
  49. Pristimerin improve renal fibrosis by regulating miRNA-145-5p in vitro and vivo study
    Chen XIAO-MEI et al, 2021, Food Sci. Technol CrossRef
  50. Triterpenoids as Reactive Oxygen Species Modulators of Cell Fate
    Taotao Ling et al, 2022, Chem. Res. Toxicol. CrossRef
  51. Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action
    Abdul Waheed Khan et al, 2022, Cells CrossRef
  52. The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art
    YingZheng Wang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  53. Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells
    Bashir A. Yousef et al, 2016, Biomedicine & Pharmacotherapy CrossRef